·µ»ØÊ×Ò³
¼²²¡ÆµµÀÎÄÕÂÅÅÐÐ
ÎÄÕÂ×ÜÅÅÐÐtop10
ʲôÊÇ»ìºÏϸ°û°×Ѫ²¡£¿
ʲôÊÇ»ìºÏϸ°û°×Ѫ²¡£¿ »ìºÏϸ°û°×Ѫ²¡£¨HAL£©ÊÇÖ¸Éæ¼°Á½¸ö»òÁ½¸öÒÔÉÏÔìѪϸ°ûϵÁеÄÌØÊâÀàÐÍ°×Ѫ²¡£¬¿ÉÄÜÆðÔ´ÓÚ¶àDZÄܶ¨ÏòÔìѪ×æϸ°û¡£ÓÉÓÚ“²»Êʵ±”µÄ¿¹Ô­±í´ïËùÖ£¬·¢²¡Âʽϵ͡£MatutesµÈ¶ÔHAL½øÐй
ʲôÊÇÂýÐÔÁ£µ¥ºËϸ°û°×Ѫ²¡£¿
ʲôÊÇÂýÐÔÁ£µ¥ºËϸ°û°×Ѫ²¡£¿ ÂýÐÔÁ£µ¥ºËϸ°û°×Ѫ²¡£¨chronic myelomonocytic leukemia£¬CMML£©¼ÈÍù±»ÈÏΪÊǹÇËèÔöÉúÒì³£×ÛºÏÕ÷£¨MDS£©µÄÒ»¸öÑÇÐÍ£¬ÒòÆä¼æÓйÇËè·¢ÓýÒì³£ºÍ¹ÇËèÔöÖ³µÄÌص㣬2001ÄêWHOÔìÑ
ʲôÊÇÊÈËáÁ£Ï¸°û°×Ѫ²¡£¿
ʲôÊÇÊÈËáÁ£Ï¸°û°×Ѫ²¡£¿ ÊÈËáÁ£Ï¸°û°×Ѫ²¡£¨EL£©ÎªÒ»ÀàÉÙ¼ûµÄ°×Ѫ²¡£¬¸÷ÄêÁä½×¶Î¾ù¿É·¢²¡£¬µ«ÒÔÖÐÀÏÄêÈËΪ¶à£¬ÄÐÐÔÃ÷ÏÔ¶àÓÚÅ®ÐÔ¡£±¾²¡µÄÁÙ´²±íÏÖÓëÆäËû°×Ѫ²¡ÏàËÆ£¬³£Óз¢ÈÈ¡¢ÏûÊÝ¡¢¹Ç÷ÀÌÛÍ´¡¢¸ÎÆ¢ÁܰͽáÖ״󣬵«
ʲôÊÇÂýÐÔÖÐÁ£Ï¸°û°×Ѫ²¡£¿ÈçºÎÕï¶Ï¼°ÖÎÁÆ£¿
ʲôÊÇÂýÐÔÖÐÁ£Ï¸°û°×Ѫ²¡£¿ÈçºÎÕï¶Ï¼°ÖÎÁÆ£¿ ÊÇÒ»ÖÖÉÙ¼ûÀàÐ͵İ×Ѫ²¡£¬ÒÔÍâÖÜѪ¼°¹ÇËèÖгÖÐø³ÉÊìÖÐÐÔÁ£Ï¸°ûÔö¶àΪÌص㡣Æð³õ¿ÉÎÞÁÙ´²Ö¢×´£¬²¡Çé½øÕ¹ÆÚ¿ÉÓеÍÈÈ¡¢Æ¶Ñª¡¢·¦Á¦¡¢ÏûÊÝÖ¢×´¡£Õï¶ÏÒªµãÈçÏ£º £¨1£©ÀÏÄê»
ʲôÊÇëϸ°û°×Ѫ²¡£¿
ʲôÊÇëϸ°û°×Ѫ²¡£¿ ëϸ°û°×Ѫ²¡£¨hairycell leukemia,HCL£©,ÊÇÒ»ÖÖBÁÜ°Íϸ°ûϵϸ°û¶ñÐÔÔöÉúµÄÂýÐÔ°×Ѫ²¡£¬1958ÄêÓÉBouroncleµÈÊ×ÏÈÌá³ö£¬²¢ÃüÃûΪ°×Ѫ²¡ÐÔÍø×´ÄÚƤϸ°ûÔöÉúÖ¢¡£ÁÙ´²ÉϽÏΪÉÙ¼û£¬·¢²¡ÄêÁäΪ
ÂýÐÔÁÜ°Íϸ°û°×Ѫ²¡ÈçºÎÖÎÁÆ£¿
ÂýÐÔÁÜ°Íϸ°û°×Ѫ²¡ÈçºÎÖÎÁÆ£¿ ¸ù¾ÝÁÙ´²·ÖÆںͻ¼ÕßÇé¿ö¶ø¶¨¡£ £¨1£©»¯Ñ§ÖÎÁÆ£ºÂýÁÜ°×Ѫ²¡Ï¸°û¾ø´ó¶àÊý´¦ÓÚÐÝÖ¹ÆÚ£¨GOÆÚ£©£¬Òò´ËÓÃϸ°ûÖÜÆÚ·ÇÌØÒìÐÔÒ©ÎïΪ¼Ñ¡£Ò»°ãAÆÚ»¼ÕßÎÞÐèÖÎÁÆ£¬¶¨ÆÚ¸´²é¼´¿É¡£B¼°CÆÚ»¼ÕßÓ¦Ó軯
ÂýÐÔÁÜ°Íϸ°û°×Ѫ²¡ÈçºÎ·ÖÆÚ£¿
ÂýÐÔÁÜ°Íϸ°û°×Ѫ²¡ÈçºÎ·ÖÆÚ£¿ ÂýÐÔÁÜ°Íϸ°û°×Ѫ²¡µÄ·ÖÆÚ¼û±í4¡£                        &nb
ºÎΪÂýÐÔÁÜ°Íϸ°û°×Ѫ²¡£¿
ºÎΪÂýÐÔÁÜ°Íϸ°û°×Ѫ²¡£¿ ÂýÐÔÁÜ°Íϸ°û°×Ѫ²¡£¨chronic lymphocytic leukemia,CLL£©ÊÇÒòÁÜ°Íϸ°û¿Ë¡ÐÔÐî»ý£¬½þÈó¹ÇË衢ѪҺ¡¢ÁܰͽáºÍÆäËûÆ÷¹Ù£¬×îÖÕµ¼ÖÂÕý³£ÔìѪ¹¦ÄÜË¥½ßµÄ¶ñÐÔѪҺ²¡¡£ÕâÀàϸ°ûÐÎ̬ÉÏ
¹²192Ìõ¼Ç¼ 16/24Ò³ Ê×Ò³ ÉÏÒ»Ò³ [11] [12] [13] [14] [15] 16 [17] [18] [19] [20] [21] ÏÂÒ»Ò³ δҳ
×îÐÂÎÄÕÂ
ÈȵãÍƼö